Rani Therapeutics (RANI) - 2022 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 RANI THERAPEUTICS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 86-3114789 (State or other jurisdiction of incorporation or organization) 2051 Ringwood Avenue San Jose, California 95131 (Address of principal executive offices) (Zip Code) (I.R.S. Employer Identification No.) Registrant's telephone ...